ALCNYSEOphthalmic GoodsFiscal year ends December 31
ALCON INC
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Feb 24, 2026
$66.13−0.05 (-0.08%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 33.4
- Dividend yield
- –
Share price
−$8.98 (−11.96%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Ex-dividend
ALCON INC grew revenue 4.9% to $10.40B over fiscal 2025. Operating income fell 3.8% to $1.36B, moving the operating margin from 14.3% to 13.1%. Free cash flow was $1.73B, up 7.7% from a year earlier.
Revenue
$10.40B
+4.9% vs. a year earlier
Operating income
$1.36B
-3.8% vs. a year earlier
Free cash flow
$1.73B
+7.7% vs. a year earlier
EPS, diluted
$1.98
-3.4% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Dec 31, 2025
Valuation
- Market cap
- –
- P/E ratio
- 33.4
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $10.40B
- Net income
- $980.00M
- EPS, diluted
- $1.98
- Free cash flow
- $1.73B
Fifteen years at a glance
Fiscal years 2006 to 2025, USD
Revenue
$10.40B+4.9% YoY
Gross profit
$5.75B+4.2% YoY
Operating income
$1.36B-3.8% YoY
Net income
$980.00M-3.7% YoY
EPS, diluted
$1.98-3.4% YoY
Free cash flow
$1.73B+7.7% YoY
Reported period